PodClips Logo

Peter Attia Intro (Part I)

0:18 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

AD: Peter's Podcast Membership Program

0:19 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Peter Introduces Dr. Michael Osterholm (Part I)

0:38 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Peter Outlines the Episode Ahead

0:40 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Peter Introduces Dr. Michael Osterholm (Part II)

0:10 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Peter Introduces Dr. Michael Osterholm (Part III)

0:54 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Michael Osterholm is Pessimistic About COVID-19's Future in the US

6:43 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

COVID-19 May Kill Millions in the United States

0:38 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

COVID-19 Isn't Disappearing Anytime Soon

0:57 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
1
Share

After Getting Infected with COVID-19, You Develop Immunity

1:31 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

If You Think COVID-19 Will Eradicate Our Species, 3 Unlikely Things Must Be True

1:36 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

COVID-19's Case Fatality Rate (CFR) Varies By Country

7:16 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

Michael Predicts COVID-19's U.S. Death Rate Will Be 1% to 2.5%

0:38 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
1
Share

With a Case Fatality Rate of 1-2%, COVID-19 is Decimating New York City

1:56 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

What Must We Do to Keep COVID-19 Deaths Below 100k in the US?

5:23 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

U.S. Healthcare Workers Fighting COVID-19 Lack Adequate Personal Protective Equipment

4:10 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

With a Lack of N95 Masks, How Can We Protect Healthcare Workers from COVID-19?

5:31 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

In the US., Supply Chain Issues Are Causing COVID-19 Testing Challenges

2:17 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Besides Testing, How Else Can We Monitor COVID-19 Infection?

3:03 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

Abbott's New COVID-19 Test May Face Supply Chain Issues

1:05 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

We Should Be Playing Chess with COVID-19, Not Checkers

0:51 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

You Don't Want COVID-19 to Hit Your City Last

0:55 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

A COVID-19 Vaccine Will Take 12+ Months to Develop

3:15 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

A COVID-19 Vaccine Would Likely Face Manufacturing Challenges

2:21 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
1
Share

Developing an Antiviral Treatment for COVID-19 is No Slam Dunk

3:28 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

We Don't Know the Long Term Health Impacts of COVID-19

2:07 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Why Do Comorbidities Predispose People to COVID-19?

1:24 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
1
Share

COVID-19 Is Quite Different from Influenza

1:08 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
2
Share

Is COVID-19's R0 Different for Asymptomatic and Symptomatic Patients?

5:07 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Did We Learn Anything from MERS Super-Spreaders That Can Be Applied to COVID-19?

1:27 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

It's Difficult to Forecast COVID-19's Future

4:15 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Michael (and Many Others) Are Disappointed in the WHO's Response to COVID-19

1:23 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Low & High Income Countries Are Competing for the Same Tools to Fight COVID-19

0:51 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Why Does COVID-19's Case Fatality Rate Vary By Country?

1:46 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Peter Interlude

0:15 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Is Michael Optimistic About Repurposed Drugs Being Used to Treat COVID-19?

1:54 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

We're Going to Get Through COVID-19; It's Just a Matter of How

0:50 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Mike & Peter Outro

0:11 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

AD: Peter's Podcast Membership Program

1:17 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Connect with Peter Online

0:10 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share

Podcast Disclaimer

1:22 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause
0
Share
ms